Will Recent $32 Billion in Opioid Settlements Prevent Addiction? Vivera Has the Answer
In response to the opioid crisis, Vivera has invented ZICOH™, a dose-controlled, electronic drug delivery device that will change the way prescription medications with a higher propensity for abuse are prescribed, dispensed, and tracked. The Company invites the parties criticized most for their role in the opioid crisis, including prescription drug manufacturers, wholesalers, distributors, and pharmacies, to be a part of the solution by partnering and investing in ZICOH.
CLICK HERE TO LEARN MORE ABOUT ZICOH™
Vivera has long understood that to tackle the opioid crisis, we first need to prevent addiction from occurring in the first place. About 25 percent of patients who are prescribed opiates for chronic pain misuse them, and about ten percent of patients taking opioids for chronic pain develop an opioid use disorder. Ultimately, opioids are killing over 100 Americans every day and are a factor in 7 out of every ten overdose deaths.
"Nearly everyone has been directly affected by or knows someone who has been affected by addiction," said
ZICOH will utilize a secure database integrated with AI to form a unique software architecture and advanced patented technology, making it the first device of its kind to enable effective communication through the drug supply chain, from drug manufacturers to wholesalers, distributors, pharmacists, providers, physicians, caregivers, and patients. The device can be programmed to dispense the medication dosage amount, type, and frequency to patients according to the health care provider's orders and delivery schedule. Each of its features helps ensure patient compliance and patient follow-up, consequentially reducing the risk of addiction and overdose.
"Our ZICOH device technology along with its elaborate, secure communication network and ecosystem has been in development and perfection for the past five years with the major goal of saving lives and providing a viable solution to the ever-increasing opioid crisis," said Mehdi Hatamian, Ph.D., Chief Scientific Advisor for Vivera. "The billions of dollars in damages, regardless of how large the number before the 'b' is, will never ever bring back the lives that were lost; it is time to act to prevent future names added to the lost-forever list."
"Vivera's ZICOH medical device is an important breakthrough and an essential clinical tool to address the opioid crisis," said
Opioids are estimated to have taken the lives of over one million people. According to preliminary data released by the
According to the lawsuits, AmerisourceBergen, Cardinal Health, McKesson, Johnson & Johnson, and Purdue Pharma played a significant role in the current state of the opioid epidemic.
Vivera is offering these parties, along with insurance companies, pharmacies, drug manufacturers, and other stakeholders, an opportunity to be part of a solution that has the potential to save millions of lives.
"We are at a pivotal moment where it's time to make a choice. Are you joining our mission to end the opioid crisis, or are you going to continue to be accused of being part of the problem?" asked CEO of Vivera,
About
For more information, please visit viverapharmaceuticals.com or connect with us on LinkedIn, Facebook, Twitter, or Instagram.
Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/will-recent-32-billion-in-opioid-settlements-prevent-addiction-vivera-has-the-answer-301498661.html
SOURCE


NEXT Insurance Appoints Insurance Veteran Jennifer Lawrence as First General Counsel
South Dakota Law Strengthens Protections for Consumers Seeking Lifetime Income in Retirement
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
More Annuity NewsHealth/Employee Benefits News
- Two May Work for You As One
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- Court: California can mandate free abortions; insurers can charge for births
- States push short-term insurance as healthcare costs climb
- WYDEN, SANDERS, SENATE DEMOCRATS CALL OUT INSURANCE COMPANY COLLUSION WITH TRUMP ADMINISTRATION TO KICK THOUSANDS OF AMERICANS OFF HEALTH INSURANCE
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
- AM Best Upgrades Credit Ratings of CTBC Insurance Company Ltd
More Life Insurance News